.
MergerLinks Header Logo

New Deal


Announced

Completed

Horizons Ventures led a $23m Series B funding round in Syzygy Plasmonics.

Synopsis

Horizons Ventures, a venture capital firm, led a $23m Series B funding round in Syzygy Plasmonics, a technology company developing the world’s highest performance photocatalyst for the industrial gas, chemical and energy industries. The round had participation from investors Equinor Ventures, The Engine, GOOSE Capital and Evok Innovations. “With renewable electricity as an energy source, our technology is cleaner, and because of the stability and activity of our photocatalysts, we can drive dozens of possibilities, tuning reactions that produce different chemicals. Our initial product will focus on eliminating emissions from hydrogen production, transforming the industrial process involved in making semiconductors, LEDs and metals. Our system will also enable industries that are consumers of hydrogen fuel cells, like fuel cell vehicles," Trevor Best, Syzygy Plasmonics Co-Founder and CEO.

Show Details & Financials

Market Context

Sort

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US